Researchers have advanced DTP3, a first-in-class drug targeting the GADD45β/MKK7 complex, into Phase 2 trials for multiple ...

The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...

The acquisition bolsters Gilead’s sputtering cell therapy business with a medication the company expects to become a ...

This reinforces the need for a CV assessment and surveillance before, during, and after the therapy, a researcher says.

How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...

How Does Sarclisa Work in Multiple Myeloma? Sarclisa is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by targeting a specific ...

Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022.

Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...

Immunotherapy is a type of cancer treatment that uses the power of a person’s immune system to fight their cancer. Instead of directly attacking cancer cells like chemotherapy or radiation, ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...

A Kentucky nonprofit is linking people newly diagnosed with cancer to trained survivors to help them navigate their journey.